Treatment Considerations for CLL
Treatment Considerations for CLL
Carsten Utoft Niemann
Fixed-Duration Therapy in CLL: Is It a Safer Option for Patients?
- 133 views
- March 23, 2023
- 2
Christopher Pleyer
Venetoclax + Obinutuzumab for Previously Untreated CLL: Latest Learnings
- 182 views
- February 13, 2023
- 2
Moffitt Cancer Center
MRD in CLL/SLL: Is It Ready for Prime Time?
FEATURING
Jose Sandoval-Sus
- 287 views
- January 25, 2023
- 5
ASH 2022 Conference Coverage
ASH 2022 Treatment of CLL-Associated Autoimmune Cytopenias and Outcomes in a Single Institution Cohort Study
FEATURING
Kerry Rogers
- 138 views
- January 4, 2023
- 1
ASH 2022 Conference Coverage
ASH 2022 Real-World OS and TTNT by 1L Therapy (BTKi and BCL2i) in Patients With CLL/SLL
FEATURING
William Archibald,
CK Wang
- 110 views
- December 16, 2022
Northwell Health
Treatment Considerations for Patients With CLL Who Are Elderly or Have Comorbid Medical Conditions
FEATURING
Joanna Rhodes
- 170 views
- December 8, 2022
SOHO 2022 Tenth Annual Meeting
SOHO 2022: BCL2i in CLL
FEATURING
Asher Chanan-Khan
- 73 views
- October 13, 2022
ERIC 2022 - European Research Initiative on CLL - ERIC
The Tumor: Biomarker-Guided Treatment in CLL
FEATURING
Othman Al-Sawaf
- 125 views
- November 8, 2022
- 2
ERIC 2022 - European Research Initiative on CLL - ERIC
Combined Inhibition of Signaling and Anti-Apoptotic Pathways in CLL
FEATURING
Peter Hillmen
- 40 views
- November 8, 2022
Arnon Kater
Updates From a MRD Model From the MURANO Trial: CLL Clonal Growth Rate Following VenR
- 174 views
- February 14, 2022